Affimed - AFMD Real Price to Acquire Entire Company
Affimed (AFMD) focuses on independent oncology drug trials, collaborating exclusively with research centers. The historical price action of the Separate Enterprise Value currently stands at . While the business develops cancer-fighting treatments, the lack of recurring sales makes its financial stability dependent on trial outcomes. Meanwhile, external risks and sanctions could disrupt raw material supplies and complicate patent protection.
&width=1200&height=400&colorIndex=0&v=mvouo2ve.rkk-7albim8&start=20220704&end=20261026&filename=GURU_Markets_-_AFMD_-_Affimed_-_Enterprise-Value "AFMD Affimed NV Business Value (07/04/2022 - 10/26/2026) | 👁️GURU.Markets👁️")
Affimed N.V. (AFMD) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Affimed (AFMD)
The capitalization of Affimed (AFMD), bolstered by payments from Roche for the development of cancer immunotherapy, directly impacts the overall business value. By summing the market value of shares and net debt, this indicator determines the actual acquisition price of the issuer, allowing for an assessment of the risk of overpaying for biopharmaceutical assets over time through the evolution of the company's enterprise value.
Competitor analysis for Affimed
argenx N.V. - Full Business Value|BNTX: Total Company Value|ABVX - Real Price to Acquire Entire Company|Enterprise Value ADMA Biologics|PTGX (protagonist-inc.com) - Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|enGene Bio - Enterprise Value|RAPT - Enterprise Value|Enterprise Value aerovatetx.com (JBIO)|aclaristx.com (ACRS) - Full Business Value|Enterprise Value Kyverna Therapeutics, Inc. KYTX|Full Business Value Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Enterprise Value|Company Buyout Price VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. - Total Company Value|Real Price to Acquire Entire Company avalotx.com AVTX|ELDN (Eledon Pharmaceuticals, Inc.) - Enterprise Value|AGEN - Total Enterprise Value|Enterprise Value Climb Bio, Inc.|Zura Bio Ltd (ZURA) - Business Value|ATYR (aTyr Pharma, Inc.) - Enterprise Value|Enterprise Value Adagene Corp|IMA - Enterprise Value|Full Business Value STTK (shattucklabs.com)|Equillium - Total Company Value|Real Price to Acquire Entire Company Connect Biopharma Holdings CNTB|Immunic Inc (IMUX) - Enterprise Value|ATRA: Business Value|Total Company Value inflarx.de (IFRX)|X4 Pharmaceuticals Inc. (XFOR) - Full Business Value|ACET - Enterprise Value|Value Adjusted for Debt and Cash Celularity Corp|Enterprise Value INMB|Enterprise Value BRNS (barinthusbio.com)|Total Company Value Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. - Value Adjusted for Debt and Cash|AKTX: Total Company Value|ENLV - Real Price to Acquire Entire Company|QTTB: Enterprise Value|Enterprise Value geovax.com|EDSA - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash iBio Inc|CARM (Carisma Therapeutics) - Enterprise Value|Company Buyout Price XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. - Total Company Value|HCW Biologics, Inc. - Real Price to Acquire Entire Company|APVO: Total Company Value|AIM ImmunoTech, Inc. (AIM) - Real Price to Acquire Entire Company|ADTX: Real Price to Acquire Entire Company|GRI (GRI Bio Corporation) - Enterprise Value|Total Company Value XORTX Therapeutics Inc. (XRTX)|Business Value reshapelifesciences.com|Revelation Biosciences, Inc. - Enterprise Value|Total Enterprise Value Indaptus Therapeutics Inc (INDP)|Enterprise Value SCNI (Scinai)|Enterprise Value CalciMedica Inc CALI|Enterprise Value Allakos Therapeutics|HOOK - Full Business Value|Enterprise Value igmbio.com (IGMS)|iTeos Therapeutics Inc (ITOS) - Full Business Value|OCEA: Enterprise Value|Company Buyout Price TCBP|Total Company Value THRD (Third Harmonic Bio)